Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105153137A reveals a cost-effective Empagliflozin synthesis route. Enhance supply chain reliability with high-purity pharmaceutical intermediates.
Novel non-chromium oxidation method for steroid intermediates. Enhances supply chain reliability and reduces environmental impact for pharmaceutical manufacturing partners globally.
Patent CN113845478B details a high-yield total synthesis of morphine derivatives. Discover supply chain security and cost reduction in pharmaceutical manufacturing with scalable routes.
Patent CN101121719A details a cost-effective route for (S)-4-ethyl-6,6-disubstituted alkoxy compounds, offering high stereoselectivity for anticancer drug manufacturing.
Discover the novel preparation method for Azilsartan Medoxomil Potassium. This report analyzes patent CN105622595A for cost reduction in API manufacturing and supply chain reliability.
Patent CN1134447C reveals a novel purification method for cefixime intermediates using tert-octylamine salts, offering high purity and scalable manufacturing solutions.
Patent CN113195454A reveals a novel synthesis route for Formula VI intermediates, offering superior purity over 99% and safer Lewis acid demethylation for scalable API manufacturing.
Patent CN115197161B details novel palladium catalysis for Z-configuration amino acids. Enables cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN121202794A reveals a novel two-step synthesis for Azilsartan isomer impurities ensuring high purity and supply chain stability for global pharmaceutical manufacturers.
Discover the advanced synthesis of (1S)-4,5-dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride. A cost-effective, scalable route for pharmaceutical supply chains.
Patent CN113214255A details a scalable four-step synthesis of 2,6-diazaspiro[3.5]nonane intermediates, offering cost-effective routes for pharmaceutical manufacturing.
Patent CN106810452B details a novel zinc amalgam reduction route for cinacalcet hydrochloride. This method ensures high purity, safety, and cost-effective commercial scale-up for global supply chains.
Patent CN106928055B reveals green aspirin synthesis. Choline-based solvents offer cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel low-cost route for Entresto key component using 4-bromobiphenyl, offering significant cost reduction and scalability for pharmaceutical manufacturers.
Patent CN112430187A reveals a novel SmI2-catalyzed reductive deuteration method for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Novel visible light method for deuterated aromatics using arylthianthrene salts. Metal-free, high yield, cost-effective for pharma intermediates.
Patent CN113292507B reveals a green synthesis route for 2-amino-6-chloroguanine, offering cost reduction in API manufacturing and eliminating high-phosphorus waste.
Patent CN111072734A reveals a high-yield route to Doxifluridine using a styryl-benzoate ribose donor, offering mild conditions and 98% coupling efficiency for API manufacturing.
Patent CN109053398B reveals single-atom catalyst method for alkyl aromatic ketones. Reduces corrosion and waste. Reliable supplier for pharma intermediates.
Patent CN101891693B reveals a cost-effective 4-step synthesis avoiding expensive sulfonium salts, offering high purity fluconazole intermediates for global supply chains.